Johnson & Johnson (JNJ) earnings · P/E 31, rev $94.19B
These earnings events as JSON? API free 100/dayJohnson & Johnson (JNJ) is a drug manufacturers - general company listed on US. It is led by Joaquin Duato.
This JNJ earnings page is the cached print — revenue, income, and the latest exhibit — not a live call transcript.
Latest reported JNJ revenue for 2025-12-28 was $94.19B. Net income was $26.80B. Revenue was up 6.0% from 2024-12-29 to 2025-12-28. JNJ currently screens at market cap $375.37B and trailing P/E 30.6.
When the next JNJ 8-K Item 2.02 lands, this page should move. Until then the SEC archive is the source.
The change that matters: Revenue was up 6.0% from 2024-12-29 to 2025-12-28. An earnings headline that ignores that move is noise.
Not investment advice. Full JNJ research stays on the stock page; the tape stays on the quote page.
JNJ earnings FAQ
What are JNJ's latest revenue and net income?
Latest cached Johnson & Johnson (JNJ) revenue for Dec 28, 2025 was $94.19B. Net income was $26.80B. Statements: https://lician.com/financials/jnj
What is JNJ's latest diluted EPS?
Latest cached Johnson & Johnson (JNJ) diluted EPS for Dec 28, 2025 was $11.03.
What period does the latest JNJ earnings print cover?
The latest cached Johnson & Johnson (JNJ) earnings print covers Dec 28, 2025. The prior cached period on this page is Dec 29, 2024.
How did JNJ revenue change from the prior cached period?
Cached Johnson & Johnson (JNJ) revenue was up 6.0% from $88.82B (Dec 29, 2024) to $94.19B (Dec 28, 2025). Statements: https://lician.com/financials/jnj
What is JNJ's P/E ratio?
Johnson & Johnson (JNJ) trailing P/E is 30.6 on the latest cached fundamentals snapshot.
Where are JNJ earnings listed?
Cached earnings facts for Johnson & Johnson (JNJ) are listed at https://lician.com/earnings/jnj. Statements: https://lician.com/financials/jnj
Not investment advice.